The potential benefits of GLP-1 medications continue to expand. New research has found that the weight loss and diabetes drugs — officially known as glucagon-like peptide 1 receptor agonists — are associated with a reduced risk of some cancers, especially in women. Researchers at Indiana University and the University of …
Read More »Weight-loss drugs now linked to cancer protection in women, major new study reveals
